Company / Current Liabilities per Share
Rein Therapeutics, Inc. Current Liabilities per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.29
FY2025
5-year range
$0.10 / $1.18
FY2021-FY2025
Trend
-75.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 9 years, ranging from $0.10 in FY2021 to $11.31 in FY2017.
Based on SEC 10-K filings.
0.29 in FY2025 with a 5-year CAGR of +14.9%.
Improved from $0.97 to $0.29 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -27.5%
- 5-Year CAGR
- +14.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 75.8% year-over-year.
- Peak current liabilities per share was recorded in FY2017.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.29 | -75.8% |
| FY2024 | $1.18 | +21.9% |
| FY2023 | $0.97 | +29.2% |
| FY2022 | $0.75 | +626.1% |
| FY2021 | $0.10 | -27.7% |
| FY2020 | $0.14 | -64.0% |
| FY2019 | $0.40 | +8.6% |
| FY2018 | $0.36 | -96.8% |
| FY2017 | $11.31 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026